D. Oh

High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer

Jae Hyun Kim, S. Lee, S. Im, 2008, British Journal of Cancer.

Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?

Jin‐Young Jang, Y. Bang, S. Im, 2016, Clinical and Translational Oncology.

Combination chemotherapy of irinotecan with fluoropyrimidine in taxane, anthracycline, and fluoropyrimidine-pretreated metastatic breast cancer.

S. Im, D. Oh, T. Kim, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of ultra-high dose rate FLASH irradiation on the tumor microenvironment in Lewis lung carcinoma: role of myosin light chain.

I. Weissman, B. Loo, P. Maxim, 2020, International journal of radiation oncology, biology, physics.

In Vivo and In Vitro Anticancer Activity of Doxorubicin-loaded DNA-AuNP Nanocarrier for the Ovarian Cancer Treatment

S. Bae, D. Oh, Chang-Seuk Lee, 2020, Cancers.

1379P Margetuximab (M) with retifanlimab (R) in HER2+, PD-L1+ 1st-line unresectable/metastatic gastroesophageal adenocarcinoma (GEA): MAHOGANY cohort A

S. Oh, A. Spira, S. Kim, 2021, Annals of Oncology.

A phase II study of imatinib mesylate as adjuvant treatment for curatively resected high-risk localized gastrointestinal stromal tumors.

S. Im, M. Ryu, W. Kang, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of MDR1/ABCB1 single nucleotide polymorphism (SNP) as a prognostic factor for breast cancer patients receiving docetaxel + doxorubicin neoadjuvant chemotherapy

B. Keam, S. Im, D. Oh, 2008 .